IMNM Stock Summary and Trading Ideas (Immunome | NASDAQ:IMNM)

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

What symbol and exchange does Immunome shares trade?

Immunome trades on the NASDAQ stock market under the symbol IMNM.

What is Immunome stock price doing today?

As of December 19, 2025, IMNM stock price climbed to $21.44 with 6,125,618 million shares trading.

What is Immunome's Beta?

IMNM has a beta of 1.26, meaning it tends to be more sensitive to market movements. IMNM has a correlation of 0.11 to the broad based SPY ETF.

How much is Immunome worth?

IMNM has a market cap of $2.37 billion. This is considered a Mid Cap stock.

How much money does Immunome make?

Last quarter Immunome reported $0 in Revenue and -$.65 earnings per share. This fell short of revenue expectation by $-727,270 and missed earnings estimates by -$.10.

What is the highest and lowest price Immunome traded in the last 3 year period?

In the last 3 years, IMNM traded as high as $30.96 and as low as $2.20.

What are the top ETFs holding Immunome?

The top ETF exchange traded funds that IMNM belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWO.

Is Immunome (IMNM) a good investment?

IMNM has outperformed the market in the last year with a price return of +93.5% while the SPY ETF gained +18.1%. IMNM has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +128.3% and +8.5%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

What are the support and resistance levels for Immunome (IMNM)?

IMNM support price is $18.84 and resistance is $21.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMNM shares will trade within this expected range on the day.